How Can We Overcome Hurdles in Clinical Lung Cancer Research?
By H Jack West, MD People with lung cancer today benefit from a growing range of new cancer treatments that provide the promise of dramatic and long-lasting responses. Whether refinements in our chemotherapy, new targeted therapies, exciting immunotherapy strategies, or other novel agents or combinations, the development of these advances is exciting and based on the completion of important clinical trials. The investigators running trials of novel agents, as well as the companies developing them and the research groups helping to manage them, are eager to enroll on these studies and learn… Read More
#LCSM Chat topic 2/25: Communicating patient goals and values for #lungcancer treatment
The best lung cancer care considers the patient’s goals and values when choosing a treatment. However, identifying and communicating those goals is not always a straightforward process for either the care provider or the patient. This week’s #LCSM Chat explores the process of communicating patient goals and values. Care providers need to know how to elicit them. Patients (even those who want to leave treatment decisions entirely to their doctors) must be able to identify and express them, and, if need be, initiate a conversation about them. Choosing the right… Read More
#LCSM 
You must be logged in to post a comment.